Arcturus, Ultragenyx ally in rare disease pact worth up to $1.6bn
- Antisense, Oligonucleotides
- Large Molecule
- Nanotechnology, Chips, etc.
- Drug Delivery
- R+D and Marketing-Licensing
- Intra-Biotech Deal
- Includes Royalty or Profit Split Information
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.